The PML protein is best known for its role as a tumor suppressor for acute promyelocytic leukemia. Both PML and the key Wnt signaling regulator AXIN regulate p53-dependent apoptosis in response to DNA damage. However, how the two major tumor suppressors coordinate with each other is unknown, and the molecular components orchestrating the PML-induced apoptosis remain enigmatic. Here we show that AXIN interacts with PML in vivo, and further that AXIN, PML and p53 form a ternary complex. Exposure to genotoxic signals including UV and doxorubicin induces AXIN to enter into the nucleus where it colocalizes with PML in the nuclear bodies. Domain-mapping experiments revealed that the C-terminal region (aa 597-832) of AXIN is responsible for its interaction with PML. AXIN fails to activate p53 in PML À/À cells, and conversely, PML is unable to activate p53 in AXIN-null SNU475 cells. Consistently, knockdown with respective siRNAs revealed that AXIN and PML depend on each other to elevate p53-Ser-46 phosphorylation and to induce apoptosis after treatment with genotoxins. Moreover, we found that dominantnegative mutants of PML blocked AXIN-induced p53 activation, and that AXIN promotes PML sumoylation, a modification necessary for PML functions. Our finding has thus provided a new avenue for understanding the mechanism by which PML activates p53 and exerts its role as a tumor suppressor.
Introduction
PML was initially identified as a fusion product linked to retinoic receptor-a, as a result of chromosomal translocation, a process found in the majority of cases of acute promyelocytic leukemia (Goddard et al., 1991; Kakizuka et al., 1991; de The´et al., 1991) . It is a key constituent of the punctate nuclear structures known as PML-nuclear bodies (PML-NB) (Ascoli and Maul, 1991; Lamond and Earnshaw, 1998; Ishov et al., 1999; Bernardi et al., 2008) . It has been shown that sumoylation is required for PML to form mature nuclear bodies (PML-NBs) (Kamitani et al., 1998; Zhong et al., 2000a; Eskiw et al., 2004; Shen et al., 2006) . Definitive evidence for the importance of PML as a tumor suppressor has come from targeted gene disruption experiment, which showed that PML À/À mice show a higher incidence of leukemogenesis, and that PML À/À cells are resistant to apoptosis induced by a variety of signals (Wang et al., 1998a, b) . Importantly, the mutant mice as well as the primary PML À/À cells are resistant to g-irradiation, indicating that PML is crucial in DNA damage response (Wang et al., 1998a, b) . Remarkably, PML regulates increasingly many other tumor suppressors, most notably p53 and pRb. PML exerts the versatile functions by regulating multiple pathways that control cell fates including induction of apoptosis, growth arrest and cellular senescence, suppression of the prosurvival and promitogenic PI3K/Akt pathway (Le et al., 1996; Quignon et al., 1998; Pearson et al., 2000; Pearson and Pelicci, 2001; Salomoni and Pandolfi, 2002; Trotman et al., 2006; Salomoni et al., 2008) . PML mediates cell death or cycle arrest caused by a wide spectrum of DNA damages and death signals in a p53-dependent or -independent manner. PML interacts with p53 and regulates p53 functions in multifaceted ways including activating its acetylation, enhancing its phosphorylation and increasing its stability (Guo et al., 2000; de Stanchina et al., 2004; Mo¨ller et al., 2003) . PML also forms complex with HIPK2, another tumor suppressor protein that is a kinase known to have a key role in phosphorylating p53 at ser-46 in response to DNA damage (D'Orazi et al., 2002; Hofmann et al., 2002) . Of important note, PML is required for HIPK2 phosphorylation of p53 (Mo¨ller et al., 2003) . Interestingly, HIPK2 seems to exert a positive feedback control of PML stability through phosphorylation (Gresko et al., 2009 ). In addition, PML can colocalize to PML-NB with Daxx that is important in the regulation of cell death in response to DNA damages (Ishov et al., 1999; Salomoni and Khelifi, 2006) . Clearly, PML is crucial for proper cellular response to genotoxic stresses.
We previously showed that AXIN, a master scaffold for Wnt signaling (Zeng et al., 1997) , serves as a platform for coordinating the activity of the protein kinase HIPK2 toward p53 at Ser-46, by forming a complex that consists of at least p53, HIPK2, Daxx and TIP60 (Rui et al., 2004; Li et al., 2007 Li et al., , 2009 . The multimeric complex is essential for DNA damage-induced apoptosis in cells after treatment of UV or doxorubicin (Dox). Interestingly, all of these AXIN-interacting partners in the p53-activating complex are also known to interact with PML (Pearson and Pelicci, 2001; Wu et al., 2009) . In particular, both AXIN and PML are required for HIPK2-mediated activation of p53 (Mo¨ller et al., 2003; Rui et al., 2004) . This prompted us to ask whether PML is a component of the AXIN-based multimeric complex or whether AXIN and PML may have a common function in DNA damage control. In this study, we have shown that AXIN interacts with PML, and that AXIN and PML depend on each other for their activation of p53 in response to genotoxic stresses. Deficiency of either one of AXIN and PML precludes the other molecule to mediate activation of p53. Moreover, there seems to exist a supramolecular complex that consists of at least AXIN, PML, HIPK2 and p53.
Results

AXIN interacts with PML
The common involvement of AXIN and PML in p53-related functions, particularly in DNA damage response, allowed us to ask whether the two proteins would physically interact with each other. Using the endogenous proteins from U2OS cells, it was found that the antibody against PML could specifically coimmunoprecipitate AXIN (Figure 1a ). The PML proteins are heterogeneous in sizes, with the upper bands most likely representing the sumoylated species.
To verify that, we carried out western blotting on the anti-PML-precipitated proteins using anti-SUMO antibody, and found that the upper bands were indeed recognized by the anti-SUMO antibody (Supplementary Figure 1a) . It was also found that treatment with different doses of Dox gave rise to different levels of AXIN co-precipitated with PML, as the lethal dose led to higher levels of AXIN co-precipitated, along with the increase of AXIN and PML after genotoxic stress. We also treated the cells with different doses of UV, and similar results were obtained (Figure 1b ; Supplementary  Figure 1b) . We further performed GST-pulldown assay and found that purified AXIN could be precipitated by GST-PML, indicating that AXIN can directly interact with PML (Supplementary Figure 1c) . We then co-transfected various AXIN constructs with wild-type PML and various PML deletion mutants with wild-type AXIN, and carried out co-immunoprecipitation experiments to determine the specific regions on AXIN and PML for their interaction. Results indicate that the C-terminal region (aa 597-832) of AXIN is responsible for interacting with the C-terminal region (aa 464-684) of PML ( Supplementary Figures 2a and b) . We also tested the interaction between AXIN and an isoform of PML (PML-2) that carries an insert of 46 aa flanking N-terminally to the AXIN-binding site. It was found that the isoform interacts with AXIN at a lesser affinity ( Supplementary Figure 2c) , suggesting that the insertion may cause certain conformational changes that weaken the interaction. We then carried out immunostaining experiments to determine whether AXIN and PML are colocalized subcellularly in untransfected U2OS cells. As shown in the upper panel of Figure 1c , AXIN (red) mainly showed cytoplasmic localization, and PML (green) was largely present in PML-NBs. We previously found that genotoxic signal UV can trigger translocation of AXIN into the nucleus (Rui et al., 2004; Li et al., 2007) . Given this, we next investigated whether under treatment with UV, AXIN and PML can colocalize in the nucleus. Indeed, AXIN was translocated into the nucleus after treatment with UV, and exhibited colocalization with PML in the nuclear bodies of apoptotic cells as judged by nuclear condensation (Figure 1c) . Moreover, as each of AXIN and PML interacts with p53, we determined whether AXIN, PML and p53 could form a ternary complex by carrying out successive co-immunoprecipitations. As shown in Figure 1d , p53 was detected in the final precipitate after the two-step co-immunoprecipitation, indicating that AXIN interacts simultaneously with PML and p53.
Mutual dependence between PML and AXIN in their activation of p53 We next determined the functional consequence of AXIN interaction with PML by measuring the level of p53 Ser-46 phosphorylation in response to DNA damage triggered by Dox or UV. In the context of untransfected cells, as shown previously (Li et al., 2009) , specific depletion of AXIN by siRNA attenuated the induction of p53 Ser-46 phosphorylation in Dox-or UV-treated cells ( Figure 2a) ; knockdown of PML also strongly attenuated the induction of p53 phosphorylation (Figure 2a ). In the same experiment, we also tested for the expression levels of p53AIP1 (p53-regulated apoptosis-inducing protein 1) that is known to be induced on severe DNA damages (Oda et al., 2000) . It was found that knockdown of PML or AXIN led to decreased expression of p53AIP1 after UV or Dox treatment (Figure 2a) , all pointing to a common role of PML and Axin in p53 activation. Using an overexpression system, we previously showed that overexpressed AXIN could lead to drastic induction of p53 phosphorylation at Ser-46, suggesting that overexpression of AXIN could phenocopy a genotoxic effect. We therefore next determined whether PML is required for overexpressed Axin to induce p53 activation. Indeed, knockdown of PML prevented AXIN from activating p53 Ser-46 phosphorylation (Figure 2b) . Similarly, knockdown of AXIN rendered PML unable to cause elevation of p53 Ser-46 phosphorylation (Figure 2c) . Furthermore, the PML dominant-negative mutants PML 3SM (SUMO acceptor sites mutated) and PML DPRB (lacking proline-rich domain, RING finger and B-Box-1) each could block AXIN-induced p53 activation (Supplementary Figure 3) . These results indicate that AXIN and PML are both required for DNA damage-induced p53 activation, and they rely on the presence of the other for p53 activation.
AXIN and PML cooperate to activate p53-dependent transcriptional activity and apoptosis
We further studied the functional relationship between AXIN and PML by assaying for their effect on the transcriptional activity of a p53-dependent reporter gene, the ability to induce cell apoptosis and on inhibition of colony formations. First, it was found that AXIN and PML could cooperatively stimulate p53 transactivational activity toward p53AIP1 in H1299 cells supplemented with trace amount (10 ng) of p53, indicating that the activation effect of AXIN and PML on p53 reporter is dependent on the participation of p53 ( Figure 3a ). Importantly, whereas AXIN could robustly stimulate the transcriptional activity of the p53 reporter, it had little effect on the same reporter in PML À/À cells ( Figure 3b ). PML failed to activate p53 transactiva- U2OS cells untreated or treated with sublethal (0.4 mM) and lethal (2.5 mM) doses of Dox were subjected to immunoprecipitation with mouse monoclonal anti-PML antibody (ab50637) for PML. The precipitates were then detected with rabbit anti-PML (ab72137) for PML, rabbit C2b for AXIN and anti-SUMO for sumoylated forms of PML. Mock represents the sample that lacked cell lysate was immunoprecipitated with anti-PML. Of note, the western blot result using anti-SUMO to show the upper bands recognized by anti-PML that contain SUMO is shown in Supplementary Figure 1a. (b) The amount of AXIN that interacts with PML is increased in cells treated with UV. U2OS cells were untreated or treated with sublethal dose (10 J/m 2 ) or lethal dose (80 J/m 2 ) of UV for 4 h, and were then subjected to immunoprecipitation and western blotting as in (a). As in (a), the western blot result using anti-SUMO is shown in Supplementary Figure 1b ). After Dox treatment for 16 and 8 h with UV, endogenous p53 was immunoprecipitated by anti-p53 DO-1 antibody, followed by western blot to determine total levels of p53 and phospho-Ser-46 p53. p53AIP1, AXIN and PML in TCL were detected to determine the interference efficiency of respective siRNAs. (b) Knockdown of PML impairs the ability of AXIN to stimulate p53 Ser-46 phosphorylation. H1299 cells were transfected with HA-AXIN, control siRNA, pSUPER-PML and Myc-p53 alone or in different combinations as indicated. After 30 h of transfection, Myc-p53 was immunoprecipitated with Myc antibody. The precipitates were subjected to western blot for determining the protein levels of total p53 and phospho-Ser-46 p53. (c) Knockdown of AXIN diminishes PML-induced p53 phosphorylation at Ser-46. HA-PML-1, control siRNA, pSUPER-AXIN and Myc-p53 were expressed alone or in different combinations in H1299 cells. IP and western blot were performed to detect phospho-Ser-46 p53 as in (b).
tional activity in AXIN-null cells SNU-475; however re-introduction of AXIN in these cells conferred PML the ability to stimulate p53 transactivational activity (Figure 3c) . Similarly, knockdown of AXIN dramatically diminished PML-stimulated transcriptional activation of p53 (Figure 3d ). Further evidence in support of the scenario that AXIN and PML activate p53-dependent transcriptional activity in a concerted manner includes the observations that PML siRNA and the dominant-negative PML mutants could drastically attenuate the ability of AXIN to stimulate the p53 reporter activity (Figures 3e and f) . As AXIN and PML
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Activity ( Figures 4a and b) . We used another luciferase reporter carrying a response element for retinoic acid receptor known as a co-activator for PML, showing that AXIN has no effect on the PML-induced reporter transcriptional activity (Supplementary Figure 4c ), indicating that AXIN-PML interaction specifically modulates the transactivity of p53. Knockdown of either AXIN or PML significantly reduced Dox-and UV-induced apoptosis of H1299 cells supplemented with p53, indicating that both AXIN and PML are involved in p53-dependent cell death triggered by lethal dose of DNA damages (Figures 4a and b) . Mutual dependence between AXIN and PML was also manifested by the observation that depletion by their respective siRNA significantly reduced the death rate induced by the other (Figures 4c and d) . Consistently, Dox-and AXIN-induced MEF cell death was drastically diminished by knockout of PML (Supplementary Figure 5a) and this effect was reversed by introducing PML in MEF PML À/À cells (Supplementary Figure 5b) . Similarly, when assayed by colony formation, AXIN showed strong dependence on PML in inhibition of cell growth. As shown in Figure 4e ectopic expression of AXIN or PML could kill cells, after co-expression of AXIN with the PML dominant-negative mutant PML 3SM or PML DPRB, the cell colonies were formed as robustly as the cells transfected with the control vector. Knockdown of PML by pSUPER-mediated siRNA blocked AXIN-induced inhibition of cell growth, further demonstrating that PML is required for AXIN-stimulated cell death.
AXIN promotes PML sumoylation
The surprising finding that AXIN is strictly required for PML-mediated DNA damage response made us further explore the molecular mechanism whereby AXIN participates in the activation of p53 by PML in response to DNA damage. Recently, it was shown that HIPK2 can phosphorylate PML and enhance SUMO modification of PML in response to DNA damage (Gresko et al., 2009) . As AXIN can stimulate the kinase activity of HIPK2 by alleviating the repression from an autoinhibitory domain (Rui et al., 2004) , we then asked whether AXIN is involved in the SUMO modification of PML. U2OS cells transfected with HA-PML and EGFP-C3 (as an internal control for transfection efficiency), and different combinations of AXIN and Myc-SUMO-1, were left untreated or treated with a lethal dose (2.5 mM) of Dox for 12h, followed by immunoprecipitation with Myc-SUMO-1 and subsequent western blotting to detect the sumoylated forms of PML in the precipitates. The result showed that AXIN can robustly increase the SUMO-1 modification of PML (Figure 5a , lane 4 compared with lane 2), to an extent similar to the stimulation by lethal DNA damage (Figure 5a , lane 3 compared with lane 2). We further show that AXIN is required for Dox-induced sumoylation of PML, as knockdown of AXIN led to a dramatic decrease of PML sumoylation (Figure 5b) .
Previous studies have shown that HIPK2-mediated phosphorylation of PML has a key role in the sumoylation of PML and that AXIN can stimulate the kinase activity of HIPK2. We next tested for the role of HIPK2 in AXIN-stimulated PML sumoylation. Knockdown of HIPK2 could robustly decrease AXIN-and Dox-stimulated sumoylation of PML, indicating that HIPK2 is indeed essential for SUMO-1 modification of PML triggered by AXIN or lethal DNA damage (Supplementary Figure 6a) . We then created PML 3S/A, a PML mutant with its three HIPK2 phosphorylation sites (Ser17, 45 and 47) mutated to Ala, and investigated the effect of AXIN and Dox on the mutant. The degree of sumoylation on PML 3S/A was drastically attenuated regardless of stimulation by AXIN or by Dox treatment compared with the wild-type PML, further showing that HIPK2-mediated phosphorylation is essential for AXIN to stimulate the sumoylation of PML (Supplementary Figure 6b) . Supramolecular complex consisting of multiple p53 regulatory factors As stated above, there exists a strict mutual functional reliance between AXIN and PML. In particular, HIPK2 and p53 known to be critical for AXIN-based DNA damage response also interact with PML. We wondered whether these proteins are co-present in a supramolecular complex. To that end, we carried out a series of pcDNA6-AXIN, pCEP4-PML-1, pCEP4-PML-1 S3M, pCEP4-PML-1 DPRB, control siRNA and pSUPER-PML were transfected alone or in combinations as indicated into U2OS cells, followed by selection with 10 mg/ml blasticidin or 200 mg/ml hygromycin B or both for 2 weeks and the surviving colonies were fixed and stained with crystal violet. co-immunoprecipitation experiments by using various antibodies, followed by western blotting of the immunoprecipitates with antibodies against the different proteins. Using the cell lysates that co-expressed the AXIN, Myc-PML, HA-HIPK2 and FLAG-p53 proteins, it was found that the anti-Myc for the Myc-tagged PML could co-immunoprecipitate AXIN, p53 and HIPK2 (Figure 6a ), indicating that AXIN, p53 and HIPK2 were all specifically co-precipitated with PML. Similarly, all of the proteins were found to be present in the immunoprecipitate by the anti-AXIN antibody (Supplementary Figure 7a) , and by the antibody for p53 (Supplementary Figure 7b) . As controls, from the cell lysates that did not express the epitope tag for the given antibody used for immunoprecipitation, the antitag antibody did not pull down any of the proteins (Figure 6a ; Supplementary Figures 7a and b , the first lanes). These results strongly suggest that the four proteins most likely coexist in the same large complex.
To determine where the multiprotein complex is formed, we co-stained PML with endogenous p53 or with stably expressed HA-HIPK2 in U2OS cells treated with or without lethal dose of UV irradiation. The results showed that UV can increase the colocalization of PML with p53 and HIPK2 in PML-NBs (Supplementary Figures 8a and b) . Together with the data in Figure 1c showing that AXIN is transferred into nucleus and colocalizes with PML in the PML-NBs on UV stimulation, it is reasonable to suggest that the supramolecular complex composed of PML, AXIN, p53 and HIPK2 is formed and distributed on PML-NBs in response to lethal DNA damages. In contrast, when coexpressed with the PML mutant PML-3SM, AXIN did not show any punctate nuclear staining despite its actual translocation into the nucleus after UV induction (Supplementary Figure 9) . This indicates that AXIN is brought to the PML-NBs by functional PML.
Discussion
We have demonstrated that AXIN interacts with PML as assessed by co-immunoprecipitation using endogenous cellular proteins and immunofluorescent staining in the cell before and after genotoxic treatment. Importantly, intensified signal in co-immunostaining between AXIN and PML in the PML-NBs was observed only after UV irradiation. Previous studies have shown that AXIN and PML share many interaction partners including HIPK2, TIP60, DAXX and p53. Our current finding that AXIN itself is a PML-associated protein points to a converging role of AXIN in tumor suppression mediated by PML, providing new avenues for understanding the molecular components of the PML supramolecular structure.
Most remarkable is that AXIN and PML strictly depend on each other for p53 activation as measured by Ser-46 phosphorylation that is a critical modification for p53 to execute apoptosis of cells subjected to DNA damage (D'Orazi et al., 2002; Hofmann et al., 2002) . First of all, knockdown of AXIN can drastically attenuate the ability of PML to induce p53 Ser-46 phosphorylation, p53-dependent transcriptional activity and apoptosis. Conversely, depletion of PML by siRNA prevented p53 Ser-46 phosphorylation, p53-dependent transcriptional activity and apoptosis induced by AXIN. Second, the PML dominant-negative mutants PML 3SM and PML DPRB entirely blocked AXIN-induced p53 Ser-46 phosphorylation, and drastically decreased p53-dependent transcription and apoptosis. The mutants also dampened the ability of AXIN to prevent cell growth as revealed by colony formation assays. Third, AXIN localization in PML-NBs depends on a functional PML, as PML 3SM fails to colocalize AXIN in the nuclear bodies (Supplementary Figure 9) , in accordance with the previous finding that PML 3SM is able to form primary PML-NB but cannot recruit many other NB components including Daxx and SP100 (Lallemand-Breitenbach et al., 2001) . Fourth, AXIN strongly promotes PML sumoylation that is a vital step for formation of PML-NBs.
Functional resemblance of AXIN to PML in DNA damage response can also be seen from the observations that both AXIN and PML exert their effects on DNA damage response through interacting with the protein kinase HIPK2, which has been shown to be essential for DNA damage-induced apoptosis, for eliciting apoptosis of cells exposed genotoxic signals (D'Orazi et al., 2002) . PML binds and stabilizes HIPK2 by protecting HIPK2 from SCFFbx3-induced degradation (Shima et al., 2008) ; interestingly, HIPK2 seems to regulate PML activity by phosphorylation reciprocally (Gresko et al., 2009 ). Here we have provided additional information on the importance of HIPK2 on PML activation by showing that HIPK2 is required for AXIN-stimulated sumoylation. Importantly, the stability of HIPK2 is also regulated by other E3 ligases, including Mdm2 and Siah-1. In unstressed cells, HIPK2 is complexed with and degraded by Siah-1, whereas in lethally DNAdamaged cells, Siah-1 becomes phosphorylated by ATM/ATR and dissociates from HIPK2 (Winter et al., 2008) . In the case of Mdm2, it is increased in sublethally damaged cells due to p53 activation and degrades HIPK2; in lethally damaged cells, Mdm2 protein is present at much lower levels, such that HIPK2 remains stable (Rinaldo et al., 2007) . Of note, it has also been reported that HIPK2 may cause apoptosis in a p53-independent manner through downregulating the transcriptional co-repressor CtBP (Zhang et al., 2003) .
Our finding that AXIN and PML are mutually dependent in the activation of p53 has further emphasized their importance as a tumor suppressor. AXIN has been shown to be mutated in human hepatocellular carcinoma (Satoh et al., 2000) , colon cancer (Jin et al., 2003) , and its loss of heterozygosity is implicated in neuroepithelial tumors (Nikuseva Martic´et al., 2010) . Although PML was initially found in promyelocytic leukemia, it is of great interest to test if PML mutations occur to other cancer cells than leukemia cells. In fact, it has been shown that expression of PML is either greatly reduced or lost in cell lines derived from many human tumors including colon adenocarcinomas and oligodendroglioma (Gurrieri et al., 2004) . In sum, we have shown that on DNA damage AXIN translocates to the nucleus where AXIN interacts with PML, HIPK2 and p53, thereby promoting PML sumoylation and HIPK2 phosphorylation of p53 at Ser-46 (Figure 6b ). Given that AXIN stability can be increased by an inhibitor (XAV939) of the ADP-ribosylation activity of its binding partner Tankyrases (Huang et al., 2009) , our identification of AXIN being an integral component in the PML complex may provide an additional clue for new therapeutic approaches for the acute promyelocytic leukemia.
Materials and methods
Expression plasmids
Full-length cDNA encoding mouse PML (PML isoform 1, GenBank accession no. NM_008884) and PML isoform 2 (GenBank accession no. NM_178087) were amplified by using total cDNA generated from mRNA of mouse brain as template, and after verification by sequencing was inserted into pCMV5. All deletion mutants and point mutations were generated as previously described (Rui et al., 2004) . The details of the primer sequences used for deletion mutations and point mutations are available on request. The plasmids pSUPER-AXIN and pSUPER-HIPK2 were as previously described (Li et al., 2009) ; pSUPER-based siRNA of PML was constructed according to the study by Bruno et al. (2003) . PGL3-p53AIP1 luciferase reporter was constructed as previously described (Oda et al., 2000) . RARE luciferase reporter was provided by Dr Qiao Wu (Xiamen University).
Antibodies and drugs
Mouse anti-HA (F-7), anti-Myc (9E10), anti-p53 (DO-1), rabbit anti-HA (Y-11), anti-p53 (FL393), anti-PML (H-238) and goat anti-PML (N-19), anti-AXIN (S20) antibodies, Texas Red bovine anti-goat IgG, Texas Red goat anti-mouse IgG and Texas Red bovine anti-rabbit IgG were purchased from Santa Cruz Biotech Inc. (Santa Cruz, CA, USA). Mouse anti-PML monoclonal antibody (PML-97), rabbit anti-PML antibody (ab72137) and rabbit anti-p53AIP1 antibodies were from Abcam (Cambridge, MA, USA). Rabbit anti-Daxx antibody (07-471) was from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Rabbit anti-phospho-p53-Ser46 was purchased from Cell Signaling Technology (Beverly, MA, USA). Alexa Fluor 488 donkey anti-rabbit IgG and Alexa Fluor 488 donkey anti-goat IgG were from Invitrogen (Carlsbad, CA, USA). HA peptide and doxorubicin (catalog no. D44583) were purchased from Sigma (St Louis, MO, USA). Blasticidin (catalog no. antbl-5b) was purchased from InvivoGen (San Diego, CA, USA). The home-made rabbit polyclonal antibody against AXIN (C2b) was as described previously (Li et al., 2009) .
Cell culture, transfection, immunoprecipitation and western blotting H1299, U2OS, SNU-475, MEF and MEF-PML À/À cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 IU penicillin, 100 mg/ml streptomycin. Transient transfections were carried out using Lipofectamine 2000 (Invitrogen) . Approximately 24 h after transfection, cells were collected for immunoprecipitation assay. Briefly, the cells were collected in 0.5 ml of the lysis buffer for immunoprecipitation, followed by western blotting as described previously (Li et al., 2009) . The detailed procedure for two-step co-immunoprecipitation was as previously described (Rui et al., 2004) . For sumoylation assays, cells were lysed in RIPA buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO4, 1 mg/ml leupeptin), sonicated and followed by immunoprecipitation with anti-Myc for SUMO-1 and western blotting with anti-HA for PML.
Immunofluorescent staining U2OS cells growing on glass coverslips were left untreated or treated with UV (80 J/m 2 ) following culture for additional 8 h, and were fixed with 3.7% formaldehyde and phosphatebuffered saline for 10 min. The staining procedures were carried as previously described (Li et al., 2009) , and visualized under a confocal laser scanning microscope (TCS SP2; Leica, Bensheim, Germany).
Transcriptional reporter assay p53AIP1 luciferase reporter and RARE luciferase reporter were used for transcriptional reporter assays. H1299, SNU-475, MEF, MEF-PML À/À or 293T cells growing in six-well dishes at 90% confluence were transfected with 0.5 mg p53AIP1 luciferase reporter or RARE luciferase reporter, together with 2 mg of other plasmids in different combinations as indicated. For each transfection, 0.5 mg each of LacZ and EGFP-C3 expression plasmid was included as internal transfection efficiency control. All transfections were carried out in triplicate for at least three times. At 24 h after transfection, luciferase activities were measured and normalized by the LacZ activity, and expression levels of AXIN, PML, p53 and green fluorescent protein (GFP) were determined by western blot.
Cell apoptosis H1299 cells were grown on 60 mm tissue culture plate. At 50% confluence, transfection was performed with 3 mg of plasmids including CMV5-AXIN, pCMV5-PML-1, control siRNA, pSUPER-AXIN pSUPER-PML and p53 in different combinations as indicated, together with 0.5 mg GFP-expressing vector pEGFPC3 (Clontech, Palo Alto, CA, USA) as internal control for transfection efficiency, followed by treatment with or without 2.5 mM Dox or 80 J/m 2 . After treatment, cells were digested and divided into two parts, with one part of cells fixed with 70% ethanol, stained with 20 mg/ml propidium iodide and determined for the percentage of apoptotic cells as judged by sub-G 1 population using a FACScan flow cytometer (EPICS XL; Beckman Coulter, Fullerton, CA, USA), and the other part for measuring protein levels by western blot. Results are presented as means ± s.d. of three independent experiments.
